First National Bank of Omaha’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-16,950
Closed -$60 362
2015
Q3
$60 Buy
16,950
+5,610
+49% +$20 ﹤0.01% 339
2015
Q2
$121 Hold
11,340
0.01% 352
2015
Q1
$121 Buy
+11,340
New +$121 0.01% 352